Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-044060

EVP, Research & CSO sold 7,900 shares at $47.99 ($379,090)

  • EVP, Research & CSO acquired 7,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-07-28 Option exercise +7,900 $1.53 $12,087 7,900 D
Virgin Herbert EVP, Research & CSO 2020-07-28 Sale −7,900 $47.99 $379,090 0 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-07-28 Option exercise · Stock Option (Right to Buy) −7,900 508,155 D
Open-market sales · 7,900 sh · avg $47.99 · $379,090
Loading xslF345X03/doc4.xml…